Purpose This study aimed to investigate the influence of residual β-cell function on counterregulatory hormonal responses to hypoglycemia during acute physical exercise in people with type 1 diabetes (T1D). A secondary aim was to explore relationships between biomarkers of pancreatic β-cell function and indices of glycemia following acute exercise including the nocturnal period.Methods This study involved an exploratory, secondary analysis of data from individuals with T1D who partook in a four-peroid, randomized, cross-over trial involving a bout of evening exercise followed by an overnight stay in a clinical laboratory facility. Participants were split into two groups: (i) a stimulated C-peptide level of ≥30 pmol⋅L−1 (low-level secretors ...
Purpose: To compare the effect of high-intensity aerobic (AER), resistance (RES), and combined (COMB...
Introduction This study sought to compare the metabolomic, hormonal and physiological responses to h...
Objective: Exercise is a cornerstone of diabetes therapy in type 1 diabetes mellitus (DMT1) patients...
Objective: To investigate the impact of residual β-cell function on continuous glucose monitoring (C...
Although important for digestion and metabolism in repose, the healthy endocrine pancreas also plays...
AIMS: Many individuals with type 1 diabetes retain residual β-cell function, with increased endogeno...
[Abstract] The onset of type 1 diabetes coincides with the final phase of β-cell destruction. In som...
Physical activity improves the regulation of glucose homeostasis in both type 2 diabetes (T2D) patie...
The aim of this study was to compare the glycemic and glucoregulatory hormone responses to low‐ and ...
Physical activity improves the regulation of glucose homeostasis in both type 2 diabetes (T2D) patie...
PhD ThesisWithin patients with type 1 diabetes (T1D), residual ꞵ-cell function and endogenous insuli...
Previous studies have demonstrated that an acute bout of aerobic exercise induces a subsequent delay...
Objective. Little is known about the influence of residual islet function on glycemic control in ...
The aim of this study was to compare the glycemic and glucoregulatory hormone responses to low- and ...
Aim: Residual β‐cell function is present at the time of diagnosis with Type 1 diabetes. Preservin...
Purpose: To compare the effect of high-intensity aerobic (AER), resistance (RES), and combined (COMB...
Introduction This study sought to compare the metabolomic, hormonal and physiological responses to h...
Objective: Exercise is a cornerstone of diabetes therapy in type 1 diabetes mellitus (DMT1) patients...
Objective: To investigate the impact of residual β-cell function on continuous glucose monitoring (C...
Although important for digestion and metabolism in repose, the healthy endocrine pancreas also plays...
AIMS: Many individuals with type 1 diabetes retain residual β-cell function, with increased endogeno...
[Abstract] The onset of type 1 diabetes coincides with the final phase of β-cell destruction. In som...
Physical activity improves the regulation of glucose homeostasis in both type 2 diabetes (T2D) patie...
The aim of this study was to compare the glycemic and glucoregulatory hormone responses to low‐ and ...
Physical activity improves the regulation of glucose homeostasis in both type 2 diabetes (T2D) patie...
PhD ThesisWithin patients with type 1 diabetes (T1D), residual ꞵ-cell function and endogenous insuli...
Previous studies have demonstrated that an acute bout of aerobic exercise induces a subsequent delay...
Objective. Little is known about the influence of residual islet function on glycemic control in ...
The aim of this study was to compare the glycemic and glucoregulatory hormone responses to low- and ...
Aim: Residual β‐cell function is present at the time of diagnosis with Type 1 diabetes. Preservin...
Purpose: To compare the effect of high-intensity aerobic (AER), resistance (RES), and combined (COMB...
Introduction This study sought to compare the metabolomic, hormonal and physiological responses to h...
Objective: Exercise is a cornerstone of diabetes therapy in type 1 diabetes mellitus (DMT1) patients...